openPR Logo
Press release

Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market is expected to reach US$ 7.64 billion by 2031 | Top key players - Madrigal Pharmaceuticals, Simson Pharma Limited, Dr. Reddy's Laboratories Ltd.

09-05-2025 02:21 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market

Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market

Market Size and Growth:

The Global Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market size reached US$ 1.67 billion in 2023 and is expected to reach US$ 7.64 billion by 2031, growing at a CAGR of 21.8% during the forecast period 2024-2031.

Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/metabolic-dysfunction-associated-steatohepatitis-treatment-market?sz

The Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market refers to the healthcare segment focused on therapies, drugs, and interventions aimed at managing and treating MASH, a progressive liver disease linked to metabolic dysfunction. The market encompasses pharmacological treatments, lifestyle interventions, and emerging therapeutic innovations designed to slow disease progression, reduce complications, and improve patient outcomes globally.

Recent Key Developments of USA and Japan:

USA:

August 15, 2025: Prime Therapeutics releases a clinical insights report highlighting the impact of Rezdiffra's FDA approval and the growing role of GLP-1s like semaglutide in treating MASH.

September 3, 2025: The FDA's Center for Drug Evaluation and Research (CDER) accepts a letter of intent to qualify Liver Stiffness Measurement by Vibration-Controlled Transient Elastography (VCTE) as a surrogate endpoint for MASH trials, potentially reducing the need for invasive liver biopsies.

Japan:

June 6, 2025: The Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA) implement new regulatory changes to accelerate drug development and approval, aiming to reduce the country's drug lag.

March 18, 2025: The MHLW announces a six-point strategy to enhance Japan's clinical research infrastructure, focusing on improving local trial systems, using decentralized and data-driven trials, and incentivizing research participation.

Market Key Players:

Madrigal Pharmaceuticals
Simson Pharma Limited
Dr. Reddy's Laboratories Ltd.
Thermo Fisher Scientific Inc.
Biosynth
Affgility Solutions
Conscientia Industrial Co. Ltd.
Smolecule Inc.
89 Bio Inc.
Sandoo Pharmaceuticals and Chemicals Co. Ltd.

Growth Forecast Projected:

The Global Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=metabolic-dysfunction-associated-steatohepatitis-treatment-market

Market Segmentation:

By Treatment: Drug, Therapy, Weight Management, Diabetes control, Regular Exercise, Foscarnet, Others.

By End-User: Hospitals, Specialty Clinics, Homecare, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/metabolic-dysfunction-associated-steatohepatitis-treatment-market

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

➠ How big is the Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment market?

➠ Who are the key players in the Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment market?

➠ What is the projected growth rate of the Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment market?

➠ What is the market forecast for the Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment industry by 2033?

➠ Which region is estimated to dominate the Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment market through the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market is expected to reach US$ 7.64 billion by 2031 | Top key players - Madrigal Pharmaceuticals, Simson Pharma Limited, Dr. Reddy's Laboratories Ltd. here

News-ID: 4171948 • Views:

More Releases from DataM Intelligence 4Market Research

Optically Clear Adhesive Market Set for Explosive Growth as OLED, Touchscreens, and AR Devices Drive Demand 2025-2032 | Top Companies - Cummins Inc, Hitachi Chemical, HB Fuller, Nitto
Optically Clear Adhesive Market Set for Explosive Growth as OLED, Touchscreens, …
Market Overview: The Global Optically Clear Adhesive Market is expected to grow at a CAGR of 8.5% during the forecast period (2024-2031). The Optically Clear Adhesive (OCA) Market refers to the global industry focused on transparent bonding materials used to laminate display panels, touchscreens, and optical components in smartphones, tablets, TVs, and automotive displays, offering high light transmission, strong adhesion, low haze, and durability to enhance visual clarity and device performance. Get a
Kaposi Sarcoma Market Set for Rapid Growth Amid Rising HIV Cases and Breakthrough Cancer Therapies 2025-2032 | Key players - Johnson & Johnson, Merck & Co., Inc., Bristol Myers Squibb
Kaposi Sarcoma Market Set for Rapid Growth Amid Rising HIV Cases and Breakthroug …
Market Overview: The Global Kaposi Sarcoma Market is expected to grow at a CAGR of 5.5% during the forecast period 2024-2031. The Kaposi Sarcoma Market comprises diagnostics, therapeutics, and supportive care for a rare vascular cancer linked to HHV-8, affecting immunocompromised and aging populations. It includes antiretroviral therapy, chemotherapy, immunotherapy, and emerging targeted treatments, driven by HIV prevalence, organ transplantation, research innovation, regulatory approvals, healthcare access, and growing awareness across developed
Bullet Proof Glass Market is expected to reach USD 45.0 billion by 2031 | Major Companies - Total Security Solutions (TSS), Saint-Gobain, PPG Industries, Inc., AGC Inc., Schott AG
Bullet Proof Glass Market is expected to reach USD 45.0 billion by 2031 | Major …
Market Size and Growth: The Global Bullet Proof Glass Market size reached USD 15.3 billion in 2022 and is expected to reach USD 45.0 billion by 2031, growing with a CAGR of 16.9% during the forecast period 2024-2031. The Bullet Proof Glass Market refers to the global industry focused on the production and supply of transparent, impact-resistant glass and laminated composites designed to withstand ballistic threats, explosions, and forced entry. These
Low-E Glass Market Set to Soar as Energy-Efficient Construction Drives Global Demand 2025-2032 | Major Companies - Guardian Industries, Schott AG, Sisecam Group, Saint-Gobain S.A.
Low-E Glass Market Set to Soar as Energy-Efficient Construction Drives Global De …
Market Overview: The Global Low-E Glass Market is estimated to grow at a CAGR of 3.3% during the forecast period 2024-2031. The Low-E Glass Market refers to the global industry producing and supplying low-emissivity coated glazing designed to improve thermal insulation by reflecting infrared heat while transmitting visible light. It is widely used in residential, commercial, and automotive applications to enhance energy efficiency, reduce heating and cooling costs, limit UV penetration,

All 5 Releases


More Releases for MASH

Key Trends Reshaping the Metabolic Dysfunction-Associated Steatohepatitis (MASH) …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market Size Growth Forecast: What to Expect by 2025? The market size pertaining to treatments for metabolic dysfunction-associated steatohepatitis (MASH) has witnessed substantial expansion lately, projected to surge from its 2024 valuation of $2 billion euros to $2.59 billion euros by 2025, reflecting a
MASH Market Momentum: Late-Stage Assets Fuel Competitive Therapeutic Landscape
Metabolic Dysfunction-Associated Steatohepatitis (MASH), formerly known as Nonalcoholic Steatohepatitis (NASH), is becoming an increasingly urgent global public health issue. This progressive liver disease, characterized by fat buildup in the liver unrelated to alcohol consumption, can lead to inflammation (hepatitis), fibrosis, cirrhosis, and eventually liver cancer. Download Strategic Sample PDF: https://datamintelligence.com/strategic-insights/sample/metabolic-dysfunction-associated-steatohepatitis-mash?ophp Akero Therapeutics Completes Enrollment for Double-Blind Phase III SYNCHRONY Real-World Study of Efruxifermin (EFX) in Patients with Non-Invasively Diagnosed MASH or MASLD
Pepper Mash Market Size Estimated to grow USD 0.517 Billion by 2032
Pepper Mash Market Overview The pepper mash market is a dynamic segment of the global food industry, characterized by its rich flavor profiles and wide-ranging applications. Pepper mash, a key ingredient in the production of hot sauces, seasonings, and processed foods, has gained significant traction due to its ability to impart heat and complexity to various dishes. This blog delves into the market overview, competitive landscape, key drivers, segmentation, and regional
Fermented Pepper Mash Market Revenue, Insights, Overview, Outlook, Analysis | Va …
Fermented Pepper Mash Market Fermented Pepper Mash is one of the most commonly used ingredients in kitchens and hot sauce manufacturers. This product is ideal for making medium-heat hot sauces and marinades. One can add small amounts to stews, soups and pastes to give them a mild flavor. Additionally, people can create their own homemade sauce by adding garlic, onions, vinegar, sugar, lemon juice, and more ingredients. According to new survey, global
Pepper Mash Market Production, Consumption, Export-Import Analysis Through 2030
** Market Overview ** Pepper mash refers to a mixture of ground black peppercorns in brine, vinegar or other solutions that is used to impart flavor, spice and heat to various food products. It is used in sauces, marinades, snacks, meat products and other culinary applications across the world. The growth of the global pepper mash market is being driven by rising demand for convenience foods, growing adoption of international cuisines and
Mash Tun Media: New UK Marketing Agency working exclusively with breweries
Mash Tun Media, the latest and most focused Digital Marketing Agency for Microbreweries has been developed and launched by the team at Future State Media. Developing niche-specific skills and understanding of the unique demands of the microbrewing market has been a passion of the team at Future State Media for the past year. Working in the brewing niche has aligned so well with existing successful projects where the team had